A61M 2202/0042
Filtrate, i.e. the fluid passing through the filter
Official title: filtrate, i.e. the fluid passing through the filter
A61M2202/0042 (Filtrate, i.e. the fluid passing through the filter) appears on 30 US grants and 41 published applications in this corpus.
Search patents in A61M- Granted patents
- 30
- Published applications
- 41
- Assignees
- 19
- Inventors
- 59
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 2 | 3 |
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 4 | 3 |
| 2018 | 1 | 0 |
| 2019 | 2 | 1 |
| 2020 | 1 | 4 |
| 2021 | 1 | 2 |
| 2022 | 1 | 0 |
| 2023 | 3 | 3 |
| 2024 | 5 | 10 |
| 2025 | 8 | 7 |
| 2026 | 2 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Evaporative fluid management canister for wound therapy system21 Jul 2026US 12,685,810 B2KCI Manufacturing Unlimited Company
- Dialysis apparatus which ultra-filters blood and a related method3 Feb 2026US 12,539,357 B2
- Extracorporeal blood filtering machine and methods30 Dec 2025US 12,508,351 B2Nuwellis, Inc.
- Treating circulating cell clusters9 Dec 2025US 12,491,304 B2OncoClear, Inc.
- Extracorporeal blood filtering machine and methods16 Sep 2025US 12,415,021 B2Nuwellis, Inc.
- Thrombus removal systems and methods for blood return and reconstituting removed blood clots18 Jun 2026US 2026/0165718 A1Shifamed Holdings, LLC
- System for removing protein bound uremic toxins during hemodialysis18 Jun 2026US 2026/0166211 A1University of Washington
- Treating circulating cell clusters12 Mar 2026US 2026/0069755 A1OncoClear, Inc.
- Therapeutic compositions for viral-associated disease states and methods of making and using same1 Jan 2026US 2026/0000821 A1Immutrix Therapeutics, Inc.
- A dialysis apparatus which ultra-filters blood and a related method28 Aug 2025US 2025/0269101 A1Ipswich Medical Research Limited
Most cited
By later US patents
- Graphene-based filter for isolating a substance from blood20US 9,572,918 B2Lockheed Martin Corporation · 2017
- Therapeutic compositions for viral-associated disease states and methods of making and using same6US 9,669,151 B2Immutrix Therapeutics, Inc. · 2017
- Infusion site for improved mixing of fluids1US 10,456,517 B2Gambro Lundia AB · 2019
- Therapeutic compositions for viral-associated disease states and methods of making and using same1US 12,409,261 B2Immutrix Therapeutics, Inc. · 2025
- Infusion site for improved mixing of fluids1US 8,715,217 B2Gambro Lundia AB · 2014